TUSC3 was initially identified as a homozygous deleted gene in metastasized prostate cancer patients and its deficiency upregulated cancer progression and tumorigenesis in ovarian, prostate, glioblastoma and pancreatic cancers20–24. This evidence concerns the gene TUSC3 and cancer.